Novitium Pharma LLC: Drug Recall
Recall #D-0443-2024 · 03/25/2024
Class III: Low Risk
Recall Details
- Recall Number
- D-0443-2024
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Novitium Pharma LLC
- Status
- Terminated
- Date Initiated
- 03/25/2024
- Location
- East Windsor, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,003 bottles
Reason for Recall
Failed Impurities/Degradation Specifications
Product Description
Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10
Distribution Pattern
U.S. Nationwide
Other Recalls by Novitium Pharma LLC
- Class III: Low Risk 03/04/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.